Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

may sustain inflammation through an

In without , inadequately edited may sustain a self-reinforcing . Recurrence despite normalized , stopped only by correcting or the surrounding , would reject the hypothesis.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 5 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Ageing mechanism

Main connectionChronic inflammation

Direction

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Lens
Endogenous rna identity
Goal
Устойчивость восстановления к закреплению повреждённого состояния
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
4 / 10Silver-bullet potential
5 / 10Support from research
Poster: Underedited RNA sustains inflammation
PosterOpen the sheet full size2026-09-30

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Extracellular nucleic acid

    Double-stranded RNA

    molecules with two paired strands that can be recognized by and trigger an

    Where this hypothesis actsIn tissue cells after prior stress, where inadequately edited transcripts persist after the initial stimulus is removed

    Hypotheses on this target 1
    Double-stranded RNASilencing. Hypotheses on this target 11Clearance restoration. Hypotheses on this target 0Neutralisation. Hypotheses on this target 0Accelerated excretion. Hypotheses on this target 0
    • Silencing1
    • Clearance restoration
    • Neutralisation
    • Accelerated excretion

    What is proposed

    Silencing

    Selectively eliminate the causal transcripts

    With whatNot stated in the record

    HowBrief, targeted degradation of the implicated transcripts

    Possible result

    Possible interruption of the self-sustaining interferon cycle and prevention of inflammatory relapse

    From the recordКраткое адресное устранение причинных РНК или восстановление их редактирования должно разорвать цикл и стабилизировать SPV_6.

  2. Enzyme

    An enzyme that edits , limiting recognition of by

    Where this hypothesis actsIn tissue cells with persistent, inadequately edited after prior stress

    Hypotheses on this target 1
    ADAR1Inhibition. Hypotheses on this target 0Activation. Hypotheses on this target 0Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Replacement. Hypotheses on this target 11Protection from degradation. Hypotheses on this target 0Cofactor removal. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Inhibition
    • Activation
    • Lower level
    • Higher level
    • Replacement1
    • Protection from degradation
    • Cofactor removal
    • Synthesis suppression
    • Function preservation

    What is proposed

    Replacement

    Restore catalytically active and its - activity

    With whatNot stated in the record

    HowRestore catalytically active , using a catalytically inactive variant as a comparison

    Possible result

    Possible prevention of inflammatory relapse that persists after the intervention is withdrawn

    From the recordАдресное разрушение этих транскриптов или восстановление каталитически активного ADAR1 предотвращает рецидив; каталитически неактивный вариант не предотвращает.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Extracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTDouble-stranded RNA. Hypotheses on this target 1Double-stranded RNA
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseAKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαADAR1. Hypotheses on this target 1ADAR1
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Inflammation may return after the conditions that first caused damage have been corrected. The unexpected move is to propose that tissue cells keep producing their own alarm signal: , a molecule made from genetic instructions, that triggers inflammation and is then replenished by that response. This is a proposal generated by the pipeline, not a measured explanation of recurring inflammation or aging.

The proposed mechanism, link by link
  1. Earlier stress is proposed to leave tissue cells persistently producing particular long molecules.
  2. Insufficient is proposed to leave those molecules able to trigger immune recognition.
  3. is proposed to detect that and activate an .
  4. The is proposed to replenish the same triggering , turning a response dependent on the original stress into a cycle that continues after the stress ends.
  5. Descendants of blood-forming cells are proposed to amplify the cycle, while tissue cells retain the ability to restart it without them.
  6. Brief removal of the responsible or restoration of its is predicted to break the cycle and leave inflammation suppressed after the intervention ends.
A picture for it

Imagine a smoke alarm connected to a machine that makes smoke whenever the alarm sounds. The original smoke can clear while the alarm and machine keep one another going.

Where the picture breaks: The biological proposal requires the inflammatory response to replenish the same that activates its detector. The picture assumes that connection exists and does not explain why a brief interruption would keep the biological cycle from restarting; both points require evidence.

  1. Master questionstep 01 of 04

    Aging processes may reinforce one another, so acting on a shared cause could benefit several body systems at once.

    Rests on: The goal is to generate ideas for extending life through a shared cause of several aging-related problems.

    Assumption

    The goal takes as its starting possibility that mutually reinforcing aging processes contain a shared cause whose modification could benefit several systems. The supplied material does not establish such a target or a lifespan benefit.

  2. Goal pillarstep 02 of 04

    Recovery should remain stable rather than allow a damaged condition to become entrenched.

    Rests on: The search for a shared cause is narrowed to the persistence of damage after recovery.

    Assumption

    The chain selects durable recovery as a route toward the master goal without establishing that the persistence of a damaged condition is a shared cause across aging systems.

  3. Gap questionstep 03 of 04

    Returning inflammation could be sustained by a lasting program in tissue cells, in that produce later generations of blood cells, or by reinforcement between them. Separate and combined temporary suppression of these programs is proposed to distinguish those possibilities.

    Rests on: The preceding stage identifies resistance to an entrenched damaged condition as the goal; this stage chooses recurring inflammation and lasting cellular programs as the concrete problem.

    Assumption

    The narrowing assumes that inflammation returns after surrounding conditions normalize and that lasting programs in these cell populations are relevant candidate explanations. The preceding stage supplies no observations establishing either premise.

  4. Hypothesisstep 04 of 04

    Previously stressed tissue cells are proposed to keep making long , whose two strands pair together, with insufficient by adenosine deaminase acting on RNA 1 (ADAR1), an enzyme that chemically changes . , a cellular detector of , would recognize this material and trigger an , an immune signaling response associated with defense against viruses. The proposed new link is that this response promotes production of the same , allowing inflammation to sustain itself after the original stress ends. Blood-cell descendants would amplify the response, but tissue alone could restart it; briefly removing the responsible or restoring is predicted to produce lasting interruption.S2S5

    Rests on: The previous stage explicitly allows tissue cells to carry a lasting inflammatory program. The supplied passage from Genome Biology (2026, S2) describes how prevents recognition of the cell’s own by , but does not establish persistent production or recurring inflammation after stress. The supplied passage from Molecular Cell (2018, S5) likewise describes long paired requiring to avoid recognition, but does not establish the proposed self-sustaining cycle or a lasting treatment effect.

    Supported by literature

What is carried, and what is not. The screened material speaks to two of the six mechanism links: changing whether the cell’s own is recognized, and sensing activating an immune response. Those links have support in the supplied Genome Biology (2026, S2) passage, but that passage does not establish persistence after stress; no supplied source establishes the proposed sequence end to end or its durable interruption.S2

Where the reasoning is carried by something unstated · 3
  • Master question. The goal takes as its starting possibility that mutually reinforcing aging processes contain a shared cause whose modification could benefit several systems. The supplied material does not establish such a target or a lifespan benefit.
  • Goal pillar. The chain selects durable recovery as a route toward the master goal without establishing that the persistence of a damaged condition is a shared cause across aging systems.
  • Gap question. The narrowing assumes that inflammation returns after surrounding conditions normalize and that lasting programs in these cell populations are relevant candidate explanations. The preceding stage supplies no observations establishing either premise.
How a result here could mislead · 3
  • Inflammation in a culture cleared of could be read as proof that ordinary tissue cells restart it independently. The rival explanation involving fused tissue and could survive removal of recognizable . What closes it: The culture’s composition must be established, including whether cells formed by remain. Attribution to ordinary tissue cells requires showing which cells produce the triggering and restart inflammation.
  • A fall in inflammation during removal or restored could be mistaken for erasure of the lasting state. Continued treatment activity could suppress inflammation while the capacity to restart remains. What closes it: The proposed post-treatment observation must establish that the intervention has ceased acting, while following the specific , its , activation and returning inflammation. The observation period and recurrence criterion must be fixed in advance; neither is specified in the supplied design.
  • More triggering after interferon stimulation could be interpreted as increased production even if existing simply lasts longer. That would not establish the proposed link in which inflammation generates more of its own trigger. What closes it: The test must distinguish newly produced from accumulated and show that interferon stimulation increases production of the same specific molecules implicated before recurrence. Measurements of amount alone cannot establish this link.

What would make this wrong. The proposal supplies a direct rejection condition: is restored, but inflammation still returns and is prevented only by correcting or the material surrounding cells. That result would contradict the claim that insufficiently edited sustains recurrence in the tested system. The central claim would also fail if interferon stimulation did not reproducibly restore production of the identified triggering under the proposed test conditions.

What it would change. If the proposal held, lasting recovery in the tested tissue could depend on interrupting a self-sustaining alarm rather than only correcting the conditions that first caused damage. Work pursuing a shared target for aging would then need to establish where this same cycle operates and whether its interruption benefits several systems. Even a successful tissue-culture test would leave effects across organs, aging in an intact organism and lifespan unestablished; the intended recovery measure called is not defined in the supplied material.

Sources read · 10

3 literature searches, 7 full texts, 3 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers itQuote unverified

Targeting ADAR1 Restores Interferon Signaling and Enhances Immunotherapy Response in Multiple Myeloma. · 2026

“Mechanistically, ADAR1 knockdown increased the association of endogenous dsRNA with melanoma differentiation-associated protein 5 (MDA5), restoring type I interferon (IFN) signaling.”

Does not settle: This source does not establish that interferon sustains production of the immunogenic transcripts through a positive feedback loop, that the cycle persists after an initial stressor is removed, or that it can restart in isolated non-malignant tissue.

S2Partly answers it

A cytoplasmic index for quantifying immune-related A-to-I RNA editing. · Genome biology · 2026

“Editing by ADAR1 disrupts the base-pairing of the immunogenic self-dsRNAs to the extent that they are no longer recognized by MDA5, or marks them otherwise, preventing inappropriate activation of the antiviral cellular immune system [ – ].”

Does not settle: Источник оставляет открытыми существование положительной интерфероновой обратной связи, сохранение программы транскрипции после стресса, автономный повторный запуск в изолированной ткани, роль кроветворных потомков, эффект краткого устранения РНК или восстановления редактирования и стабилизацию SPV_6.

S3Partly answers itAbstract only

Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway. · Cancer letters · 2025

“Our findings revealed that knockout Adar1 induces dsRNA accumulation, activating the TBK1-IRF3 pathway and stimulating interferon stimulating genes (ISGs) expression, which in turn activates anti-tumour immunity and suppresses lung cancer growth.”

Does not settle: Abstract reports ADAR1 loss in lung cancer cells. It does not establish a persistent interferon positive-feedback loop, prior stress, production of specific long dsRNA transcripts, autonomous reactivation in isolated tissue, hematopoietic contribution, or effects of transient RNA removal or restored editing on SPV_6.

S4BackgroundAbstract only

Retinoic acid-inducible gene-I-like receptors. · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2011

“Because RLRs are IFN-inducible viral sensors, they are critical in amplifying antiviral responses.”

Does not settle: This abstract does not establish endogenous underedited RNA, ADAR1 involvement, MDA5 sensing of self RNA, persistence after stress, isolated-tissue re-initiation, or an interferon-driven loop producing immunogenic transcripts.

S5Partly answers it

Cryo-EM Structures of MDA5-dsRNA Filaments at Different Stages of ATP Hydrolysis. · Molecular cell · 2018

“mRNA containing Alu repeats, endogenous retroelements of viral origin constituting 10% of the human genome, can hybridize into long RNA duplexes that must be deaminated by ADAR1 to avoid recognition by MDA5”

Does not settle: Источник описывает распознавание длинной двуцепочечной РНК MDA5 и необходимость редактирования ADAR1, но не устанавливает положительную обратную связь, при которой интерфероновый ответ поддерживает образование иммуногенных транскриптов, её сохранение после устранения стресса, повторный запуск в изолированной ткани, вклад кроветворных потомков или эффективность краткого устранения РНК либо восстановления редактирования.

S6Partly answers it

Control of retrotransposon-driven activation of the interferon response by the double-stranded RNA binding protein DGCR8. · Nucleic acids research · 2026

“To this end, we generated DGCR8 knockout human cell lines and found that DGCR8 loss triggers a spontaneous type I IFN response. We show that the MDA5-MAVS pathway is responsible for the activation of the IFN response.”

Does not settle: This source text does not establish ADAR1-dependent underediting, persistence after a prior stress, an interferon-driven positive feedback loop sustaining immunogenic transcripts, tissue-autonomous recurrence, hematopoietic contributions, or whether RNA removal or restored editing stabilizes SPV_6.

S7BackgroundAbstract only

Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression. · Current diabetes reports · 2015

“Melanoma differentiation-associated protein 5 (MDA5), encoded by IFIH1, mediates the innate immune system's interferon response to certain viral species that form double-stranded RNA (dsRNA), the MDA5 ligand, during their life cycle.”

Does not settle: This abstract does not establish ADAR1-dependent underediting of endogenous RNA, persistent immunogenic transcripts after stress, a self-sustaining interferon feedback loop, tissue-autonomous reactivation, hematopoietic contribution, or effects of removing causal RNAs or restoring editing.

S8Partly answers it

Mutant TP53 hijacks RNA-splicing factor RBM28 to suppress double-stranded RNA triggered antitumor immunity. · Nature communications · 2026

“These TEs trigger innate immune sensing not only through the dsRNA they produce—which is recognized by intracellular sensors such as RIG-I-like receptors (RIG-I and MDA5) to initiate type I interferon (IFN) production —but also through other nucleic acid components.”

Does not settle: This source does not establish ADAR1 underediting, persistence after prior stress, an interferon-driven positive feedback loop producing immunogenic transcripts, autonomous restarting in isolated tissue, hematopoietic amplification, or effects of targeted RNA removal or restored editing.

S9Partly answers it

Distinguishing self from non-self RNA by editing-specific inosine patterns. · 2026

“Endogenous dsRNAs are normally masked as “self” by A-to-I RNA editing through adenosine deaminases acting on RNA (ADARs), which prevents inadvertent activation of antiviral signaling [ – ].”

Does not settle: The source does not establish that interferon sustains production of the same immunogenic transcripts through a positive feedback loop after the initial stress is removed, that recurrence occurs in isolated tissue, the contribution of hematopoietic descendants, or that transient RNA removal or restored editing stabilizes SPV_6.

S10Partly answers it

An Ultrastructural and Proteomic Analysis in DM1 Young Adults' Myoblasts: Stressed RER and Mitochondrial Dysfunction Involvement. · Journal of cellular and molecular medicine · 2026

“These transcripts may form stable, toxic base‐paired hairpin structures that translocate from the nucleus to the cytoplasm, forming dsRNAs that represent a danger signal within the cell.”

Does not settle: The source does not establish impaired ADAR1 editing, MDA5 sensing, an interferon-driven positive feedback loop that generates these transcripts, persistence after removal of an initial stressor, tissue-autonomous reactivation, or whether RNA removal/editing restoration stabilizes SPV_6.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Does temporarily silencing memory in tissue cells, blood-forming cells, or both stop inflammation returning after conditions improve?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Что возвращает воспаление после нормализации среды: , память или их взаимное подкрепление, выявляемое раздельным и совместным этих программ?

What this question is asking

The question asks where lasting changes that might restart inflammation are stored. It compares memory within tissue cells, memory in the that produce , and a cycle in which these two sources keep reactivating each other. The proposed comparison is between temporarily suppressing each memory program separately and suppressing both together after the original harmful conditions have been corrected. The question assumes that memory of physical conditions in tissue cells and inherited memory of altered cellular chemistry have already been demonstrated separately, but that their interaction in an aged organism remains unresolved. Its intended measure of success is recovery toward a common stable condition over weeks, followed by limited remaining loss of function during repeated challenges over months; the supplied material does not specify the challenges or acceptable limits.

What the terms mean
Inflammation
A response involving and tissue signals to injury or harmful exposure. Here, the outcome is whether that response returns after the original harmful conditions are corrected.
Cellular or inflammatory memory
A lasting change caused by an earlier exposure that alters a cell's later behavior or the behavior of its descendants. It names a class of effects, not conscious memory or one universally defined program.
Tissue cells and autonomous tissue-cell memory
Tissue cells are cells within organs; the question contrasts them with blood-forming precursors. Autonomous memory would mean that a retained change within those tissue cells contributes to later behavior without continued exposure to the original trigger; it does not necessarily mean independence from every outside signal.
Blood-forming stem and precursor cells
Cells that give rise to blood cells, including . Stem cells can maintain their own population, while precursors are further along the path toward particular blood-cell types; memory in this compartment could affect subsequently produced cells.
Immune cells
Cells involved in defense and responses to damage. The question concerns whether their behavior reflects lasting changes in the cells that produced them.
Mechanical memory
A lasting cellular effect of earlier physical conditions, such as forces or the properties of surrounding material. The pipeline labels this component RL-1, but supplies no definition of that label or direct finding establishing the particular program.
Metabolism and inherited metabolic memory
Metabolism is the set of chemical processes through which cells obtain and use energy and materials. Inherited metabolic memory here means that effects of an earlier metabolic state persist in descendant cells, rather than inheritance between parents and offspring; the pipeline labels it RL-2 without defining that label.
Memory program and reversible suppression
A memory program is shorthand for cellular processes that maintain an exposure's lasting effects. Reversible suppression means temporarily reducing those processes and then allowing the suppressing effect to end; temporary improvement alone would not establish permanent removal of memory.
Mutual reinforcement
A cycle in which changes in one cell group help maintain or restore changes in another, which then acts back on the first. It is one of the possibilities being asked about, not a demonstrated relationship in the supplied evidence.
Environmental correction
Removal or correction of the harmful conditions thought to sustain inflammation. The input does not specify those conditions or a measurement confirming that they have been corrected.
Functional deficit
A remaining reduction in how well a tissue or organism works. The pipeline asks for this loss to remain limited, but supplies neither the function being measured nor its acceptable limit.
Epithelial cells
Cells that cover body surfaces and line internal spaces and organs. S3 identifies them as cells capable of acquiring memory.
Cell-surface signaling protein
A protein at a cell's surface that helps transmit signals into the cell when an activating partner binds. In S2, memory preserves such a protein, supporting continued responsiveness to activating signals.
Neutrophils
A type of immune cell produced from blood-forming cells. S8 measures their increased arrival in the abdominal cavity during a subsequent infection.
Candida albicans
The fungal species used for the earlier exposure and subsequent infection in S8. That result concerns a response to infection, rather than demonstrated spontaneous return of inflammation after environmental correction.
What the question takes for granted
Premise only partly supported
Mechanical memory in tissue cells and inherited metabolic memory in blood-forming precursors have been demonstrated separately, and their interaction in an aged organism has not been established.

Tissue cells are cells within an organ, while blood-forming precursors generate blood cells, including . The assumption is that the first group can retain effects of earlier physical conditions and the second can pass effects of altered cellular chemistry to its descendants. If established in the relevant setting, these would provide two distinct sources whose contributions to returning inflammation could be compared.

The sources support a narrower premise: lasting changes occur in some tissue-cell settings, and prior exposure of blood-forming cells can affect the responses of their descendants. S2 reports inflammatory memory in pancreatic cancer cells, and S3 reports that cells covering or lining body surfaces acquire memories in living organisms. S8 reports a changed response in descended from previously exposed blood-forming cells in mice. These findings do not establish the specific mechanical and inherited metabolic programs named in the pipeline statement, their persistence after environmental correction in aged organisms, or their mutual reinforcement. None of the supplied excerpts establishes their interaction; that limitation does not establish that the wider literature lacks such work.S2S3S8

The same question asked without the part nothing read establishes:

  • After harmful conditions are corrected, does temporarily suppressing lasting changes in tissue cells, blood-forming precursors, or both prevent inflammation from returning?
  • What evidence distinguishes tissue-cell memory from blood-forming-precursor memory as a source of returning inflammation after harmful conditions are corrected?
What turns on the answer
  • Tissue-cell memory sustains recurrence Under this outcome, tissue cells would retain the change that restarts inflammation after their surroundings improve. Suppressing that memory would prevent recurrence under the conditions examined, while suppressing memory only in blood-forming precursors would leave the tissue source active.
  • Blood-forming-precursor memory sustains recurrence Under this outcome, blood-forming precursors would continue producing with an altered response. Suppressing that precursor memory would prevent recurrence under the conditions examined, while suppressing tissue-cell memory alone would leave the continuing supply of altered .
  • Both memories reinforce each other Under this outcome, activity arising from either cell group would help restore the altered state in the other. Separate temporary suppression would therefore permit recurrence, whereas joint suppression could interrupt the cycle; persistence of that interruption after suppression ends would determine whether recovery lasts.
  • Neither proposed memory explains recurrence If recurrence continued despite effective joint suppression, these two memories would not sufficiently explain its return. The question's proposed choice between them would then leave the actual cause unresolved.
Why it matters

Correcting an ongoing source of inflammation and removing a lasting change caused by that source are different steps. If tissue cells retain a change that restarts inflammation, correcting their surroundings could leave that source of recurrence intact. If blood-forming precursors retain the relevant change, the they subsequently produce could instead carry the altered response forward. If the two sources reactivate each other, suppressing only one could allow the other to restore the cycle. These are conditional consequences of the question's proposed mechanism: confusing them could lead to mistaking temporary improvement for lasting recovery.

What is already established

RL-1 и RL-2 показаны раздельно; их взаимодействие в старом организме не установлено.

What would have to be true

После устранения стимула траектории сходятся за недели; остаточный остаётся ниже заданных границ при повторных нагрузках месяцами.

What is missing

Неизвестно, какая память восстанавливает патологическое состояние после коррекции среды и достаточно ли устранения одного источника для устойчивого общего эффекта.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Автономное возвращение воспаления возникает из-за нарушения распознавания собственной (). После прежнего стресса в тканевых клетках сохраняется программа образования длинных , которые недостаточно . воспринимает их как опасный материал и запускает . Ключевое новое предположение состоит в : поддерживает образование именно этих , позволяя циклу пережить устранение первоначального стимула. усиливают реакцию, но её повторный запуск возможен в изолированной ткани. Краткое адресное устранение причинных или восстановление их должно разорвать цикл и стабилизировать .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

В после удаления возвращению воспаления предшествуют рост конкретных и активация . или восстановление предотвращает рецидив; вариант не предотвращает. Для доказательства краткое вмешательство должно давать эффект после своей отмены, а должна воспроизводимо восстанавливать образование причинных . Если , но воспаление возвращается и устраняется только коррекцией или , гипотеза отвергается.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable intervention outcomes, persistence after withdrawal, reproducible restoration, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Доступны , , и сравнение активного и неактивного . Исследование показало, что потеря его вызывает распознавание через . [Liddicoat et al., Science, 2015](https://pubmed.ncbi.nlm.nih.gov/26275108/). Долговременная при старении требует самостоятельного доказательства.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

В после удаления возвращению воспаления предшествуют рост конкретных и активация . или восстановление предотвращает рецидив; вариант не предотвращает. Для доказательства краткое вмешательство должно давать эффект после своей отмены, а должна воспроизводимо восстанавливать образование причинных . Если , но воспаление возвращается и устраняется только коррекцией или , гипотеза отвергается.

  • What would separate them

    Cell fusion may restart inflammation by combining tissue and immune programs in persistent hybrids predicts: После раздельного и совместного тканевой и кроветворной программ воспаление возвращается преимущественно из клеток, в которых подтверждены обеих . Удаление только этих клеток устраняет рецидив после повторной малой нагрузки; удаление такого же числа соседних этого эффекта не даёт. Обнаружение устойчивого рецидива в культурах с надёжно исключённым и его устранение коррекцией , или опровергает гипотезу как основное объяснение.

  • What would separate them

    Wider cell contacts may prevent enzyme exclusion, impair clearance and renew inflammation predicts: При одинаковых , , составе клеток и текущей среде изменение только длины меняет присутствие в , и вероятность завершённого . Короткий восстанавливает очистку и предотвращает последующее воспаление при сохранении прежних . Укорочение внеклеточной части должно отменять этот эффект, поскольку укороченная снова помещается в . Отсутствие такой зависимости при подтверждённом изменении расстояния отвергает геометрическое объяснение.

  • Rival 03 of 03
    Matrix breakdown may restart inflammation through a peptide-driven feedback loop

    Not yet published.

    What would separate them

    Matrix breakdown may restart inflammation through a peptide-driven feedback loop predicts: ранее повреждённой ткани запускает привлечение в системе из клеток без прежней истории воздействия. Эффект исчезает после избирательного удаления и возвращается при добавлении в измеренной исходной концентрации. Замена клеток при сохранённом допускает рецидив; химическая обработка при сохранённых клетках предотвращает его. Сохранение эффекта после подтверждённого удаления причинных , особенно при зависимости от или геометрии , опровергает гипотезу.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

1 of 1 cited studies could be located, and 0 of 0 figures are not carried by one that resolved.

CitationsEvery citation resolvedFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

1 citation handle extracted; 2 Europe PMC searches run; 3 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.